Dr. Hennemeyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 800-926-8273Fax+1 888-539-8781
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Vascular and Interventional Radiology, 2006 - 2007- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiology-Diagnostic, 2002 - 2006
SSM Health/Saint Louis University School of MedicineInternship, Internal Medicine, 2001 - 2002- Saint Louis University School of MedicineClass of 2001
Certifications & Licensure
AZ State Medical License 2012 - 2026
CA State Medical License 2003 - 2025
CO State Medical License 2024 - 2025
NY State Medical License 2010 - 2024
ME State Medical License Active through 2014
PA State Medical License 2010 - 2012- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Clinical Trials
- Quantitative Assessment of RV Strain Using cMRI Following Catheter Intervention on PE Start of enrollment: 2017 Dec 01
- Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy Start of enrollment: 2017 Jul 26
Publications & Presentations
PubMed
- 1 citationsMeasurement of the Tumor-to-Normal Ratio for Radioembolization of Hepatocellular Carcinoma: A Prospective Study Comparing 2-Dimensional Perfusion Angiography, Techneti...Christopher P Brunson, Hugh J McGregor, Charles T Hennemeyer, Mikin V Patel, Gregory J Woodhead
Journal of Vascular and Interventional Radiology. 2024-01-01 - 1 citationsPrior ablation and progression of disease correlate with higher tumor-to-normal liverTc-MAA uptake ratio in hepatocellular carcinoma.Mikin V Patel, David McNiel, Christopher Brunson, Phillip H Kuo, Charles T Hennemeyer
Abdominal Radiology. 2023-02-01 - 3 citationsTilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINA...Hani Babiker, Erkut Borazanci, Vivek Subbiah, Sanjiv Agarwala, Alain Algazi
Clinical Cancer Research. 2022-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
